193 related articles for article (PubMed ID: 35760608)
1. Herpes simplex virus type 1 (HSV-1) over-infection in patients with acute respiratory distress syndrome secondary to COVID-19 pneumonia: Impact on mortality.
Pérez-Pedrero Sánchez-Belmonte MJ; Sánchez-Casado M; Moran Gallego FJ; Piza Pinilla R; Gomez Hernando C; Paredes Borrachero I
Med Clin (Barc); 2023 Jan; 160(2):66-70. PubMed ID: 35760608
[TBL] [Abstract][Full Text] [Related]
2. Herpes simplex virus type 1 (HSV-1) over-infection in patients with acute respiratory distress syndrome secondary to COVID-19 pneumonia: Impact on mortality.
Pérez-Pedrero Sánchez-Belmonte MJ; Sánchez-Casado M; Moran Gallego FJ; Piza Pinilla R; Gomez Hernando C; Paredes Borrachero I
Med Clin (Engl Ed); 2023 Jan; 160(2):66-70. PubMed ID: 36590241
[TBL] [Abstract][Full Text] [Related]
3. Effect of the duration of prone position in ARDS patients during the SARS-CoV-2 pandemic.
de Miguel-Balsa E; Blasco-Ruso T; Gómez-Medrano N; Mirabet-Guijarro M; Martínez-Pérez A; Alcalá-López A
Med Intensiva (Engl Ed); 2023 Oct; 47(10):575-582. PubMed ID: 37147214
[TBL] [Abstract][Full Text] [Related]
4. Acute respiratory distress syndrome due to COVID-19. Clinical and prognostic features from a medical Critical Care Unit in Valencia, Spain.
Ramírez P; Gordón M; Martín-Cerezuela M; Villarreal E; Sancho E; Padrós M; Frasquet J; Leyva G; Molina I; Barrios M; Gimeno S; Castellanos Á
Med Intensiva (Engl Ed); 2021; 45(1):27-34. PubMed ID: 32919796
[TBL] [Abstract][Full Text] [Related]
5. High dose dexamethasone treatment for Acute Respiratory Distress Syndrome secondary to COVID-19: a structured summary of a study protocol for a randomised controlled trial.
Maskin LP; Olarte GL; Palizas F; Velo AE; Lurbet MF; Bonelli I; Baredes ND; Rodríguez PO
Trials; 2020 Aug; 21(1):743. PubMed ID: 32843098
[TBL] [Abstract][Full Text] [Related]
6. Characterisation and outcomes of ARDS secondary to pneumonia in patients with and without SARS-CoV-2: a single-centre experience.
Mahida RY; Chotalia M; Alderman J; Patel C; Hayden A; Desai R; Beesley E; Crowley LE; Soltan M; Bangash M; Parekh D; Patel J; Thickett DR
BMJ Open Respir Res; 2020 Nov; 7(1):. PubMed ID: 33257441
[TBL] [Abstract][Full Text] [Related]
7. Herpes Simplex Virus Type 1 Pneumonia-A Review.
Jellinge ME; Hansen F; Coia JE; Song Z
J Intensive Care Med; 2021 Dec; 36(12):1398-1402. PubMed ID: 33926298
[TBL] [Abstract][Full Text] [Related]
8. Impact of herpes simplex virus detection in respiratory specimens of patients with suspected viral pneumonia.
Scheithauer S; Manemann AK; Krüger S; Häusler M; Krüttgen A; Lemmen SW; Ritter K; Kleines M
Infection; 2010 Oct; 38(5):401-5. PubMed ID: 20589523
[TBL] [Abstract][Full Text] [Related]
9. Clinical characteristics of pediatric patients with acute respiratory distress syndrome due to COVID-19.
Marroquín-Yáñez ML; Medeiros M; Chávez-López A; Carrillo-López HA; Soto-Bautista NP; Jarillo-Quijada AE; Gómez-Murillo SY; Láscari-Jiménez EC; Ruiz-Quiñones G; Barrera-Alonzo CJ; Contras-Santiago EM; Hernández-Hernández M
Bol Med Hosp Infant Mex; 2022; 79(3):170-179. PubMed ID: 35882022
[TBL] [Abstract][Full Text] [Related]
10. [Herpes simplex virus pneumonia].
Luyt CE
Virologie (Montrouge); 2020 Oct; 24(5):307-313. PubMed ID: 33111704
[TBL] [Abstract][Full Text] [Related]
11. High rate of HSV-1 reactivation in invasively ventilated COVID-19 patients: Immunological findings.
Seeßle J; Hippchen T; Schnitzler P; Gsenger J; Giese T; Merle U
PLoS One; 2021; 16(7):e0254129. PubMed ID: 34197543
[TBL] [Abstract][Full Text] [Related]
12. Effect of Antiviral Therapy on the Outcome of Mechanically Ventilated Patients With Herpes Simplex Virus Type 1 in BAL Fluid: A Retrospective Cohort Study.
Heimes E; Baier M; Forstner C; Weis S; Bauer M; Fritzenwanger M; Scherag A; Pletz MW; Kesselmeier M; Hagel S
Chest; 2020 Nov; 158(5):1867-1875. PubMed ID: 32629035
[TBL] [Abstract][Full Text] [Related]
13. Reactivation of Herpes Simplex Virus Type 1 (HSV-1) Detected on Bronchoalveolar Lavage Fluid (BALF) Samples in Critically Ill COVID-19 Patients Undergoing Invasive Mechanical Ventilation: Preliminary Results from Two Italian Centers.
Giacobbe DR; Di Bella S; Dettori S; Brucci G; Zerbato V; Pol R; Segat L; D'Agaro P; Roman-Pognuz E; Friso F; Principe L; Lucangelo U; Ball L; Robba C; Battaglini D; De Maria A; Brunetti I; Patroniti N; Briano F; Bruzzone B; Guarona G; Magnasco L; Dentone C; Icardi G; Pelosi P; Luzzati R; Bassetti M
Microorganisms; 2022 Feb; 10(2):. PubMed ID: 35208817
[TBL] [Abstract][Full Text] [Related]
14. Intensive care for seriously ill patients affected by novel coronavirus sars - CoV - 2: Experience of the Crema Hospital, Italy.
Zuccon W; Comassi P; Adriani L; Bergamaschini G; Bertin E; Borromeo R; Corti S; De Petri F; Dolci F; Galmozzi A; Gigliotti A; Gualdoni L; Guerra C; Khosthiova A; Leati G; Lupi G; Moscato P; Perotti V; Piantelli M; Ruini A; Sportelli S; Susca M; Troiano C; Benelli G; Buscarini E; Canetta C; Merli G; Scartabellati A; Melilli B S C G; Sfogliarini R; Pellegatta G; Viganò G
Am J Emerg Med; 2021 Jul; 45():156-161. PubMed ID: 33046317
[TBL] [Abstract][Full Text] [Related]
15. Prone positioning in COVID-19 patients with acute respiratory distress syndrome and invasive mechanical ventilation.
Barja-Martínez E; García-González S; Jiménez-García E; Thuissard-Vasallo IJ; Arias-Rivera S; Blanco-Abril S
Enferm Intensiva (Engl Ed); 2023; 34(2):70-79. PubMed ID: 36934077
[TBL] [Abstract][Full Text] [Related]
16. HSV-1 reactivation is associated with an increased risk of mortality and pneumonia in critically ill COVID-19 patients.
Meyer A; Buetti N; Houhou-Fidouh N; Patrier J; Abdel-Nabey M; Jaquet P; Presente S; Girard T; Sayagh F; Ruckly S; Wicky PH; de Montmollin E; Bouadma L; Sonneville R; Descamps D; Timsit JF
Crit Care; 2021 Dec; 25(1):417. PubMed ID: 34872611
[TBL] [Abstract][Full Text] [Related]
17. Is acyclovir effective among critically ill patients with herpes simplex in the respiratory tract?
Traen S; Bochanen N; Ieven M; Schepens T; Bruynseels P; Verbrugghe W; Jorens PG
J Clin Virol; 2014 Jul; 60(3):215-21. PubMed ID: 24800905
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for
Fuest KE; Erber J; Berg-Johnson W; Heim M; Hoffmann D; Kapfer B; Kriescher S; Ulm B; Schmid RM; Rasch S; Lahmer T
Multidiscip Respir Med; 2022 Jan; 17(1):815. PubMed ID: 35340709
[TBL] [Abstract][Full Text] [Related]
19. Effect of early treatment with polyvalent immunoglobulin on acute respiratory distress syndrome associated with SARS-CoV-2 infections (ICAR trial): study protocol for a randomized controlled trial.
Mazeraud A; Gonçalves B; Aegerter P; Mancusi L; Rieu C; Bozza F; Sylla K; Siami S; Sharshar T
Trials; 2021 Feb; 22(1):170. PubMed ID: 33648563
[TBL] [Abstract][Full Text] [Related]
20. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
